Journal Article

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer

Thirukkumaran, Chandini, Thirukkumaran, Ponnampalam, Luider, Joanne, Elzinga, Kate, Kopciuk, Karen, Morris, Don, Spurrell, Jason, Shi, Zhong-Qiao

2017

Overview

Reovirus is a ubiquitous RNA virus that exploits aberrant signaling pathways for its replication. The oncolytic potential of reovirus against numerous cancers under pre-clinical/clinical conditions has been documented by us and others. Despite its proven clinical activity, the underlying mechanisms of reovirus oncolysis is still not well elucidated. If reovirus therapy is to be optimized for cancer, including breast cancer patients, it is imperative to understand the mechanisms of reovirus oncolysis, especially in treatment of resistant tumour. In the present study global gene expression profiling was utilized as a preliminary roadmap to tease-out pivotal molecules involved in reovirus induced apoptosis in breast cancer. Reovirus treated HTB133 and MCF7 breast cancer cells revealed transcriptional alteration of a defined subset of apoptotic genes and members of the nuclear factor-kappa B (NF-kB) family and p53 upregulated modulator of apoptosis (PUMA) were prominent. Since NF-kB can paradoxically suppress or promote apoptosis in cancer, the significance of NF-kB in reovirus oncolysis of breast cancer was investigated. Real time PCR analysis indicated a 2.9-4.3 fold increase in NF-kB p65 message levels following reovirus infection of MCF7 and HTB133, respectively. Nuclear translocation of NF-kB p65 protein was also dramatically augmented post reovirus treatment and correlated with enhanced DNA binding. Pharmacologic inhibition of NF-kB lead to oncolytic protection and significant down regulation of PUMA message levels. PUMA down regulation using siRNA suppressed reovirus oncolysis via significantly repressed apoptosis in p53 mutant HTB133 cells. This study demonstrates for the first time that a prominent pathway of reovirus oncolysis of breast cancer is mediated through NF-kB and that PUMA upregulation is dependent on NF-kB activation. These findings represent potential therapeutic indicators of reovirus treatment in future clinical trials.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Aberration / Apoptosis / Apoptosis - physiology / Apoptosis Regulatory Proteins - genetics / Apoptosis Regulatory Proteins - metabolism / Biology and Life Sciences / Breast cancer / Breast Neoplasms - therapy / Cancer / Cancer therapies / Care and treatment / Cell Line, Tumor / Clinical trials / Colorectal cancer / Deoxyribonucleic acid / DNA / Electrophoretic Mobility Shift Assay / Gene expression / Health aspects / Humans / Laboratories / Leukemia / Lung cancer / MCF-7 Cells / Medical research / Medicine and Health Sciences / Mutation / NF-κB protein / Nuclear transport / Oncolysis / Oncolytic Virotherapy - methods / p53 Protein / Pharmacology / Protein transport / Proto-Oncogene Proteins - genetics / Proto-Oncogene Proteins - metabolism / Reoviridae / Reoviridae - physiology / Reoviruses / Research and Analysis Methods / Ribonucleic acid / RNA / RNA Interference / RNA viruses / RNA, Small Interfering - genetics / Signal transduction / Signal Transduction - physiology / Signaling / siRNA / Synaptotagmin / Transcription / Transcription Factor RelA - metabolism / Transcription factors / Translocation / Tumor necrosis factor-TNF / Tumors / Viruses